NCT02807675 A Study of the Safety and Tolerability of a Single Dose Administration of CVT-301 (Levodopa Inhalation Powder) Status COMPLETED Phase PHASE1
NCT02797496 Comparison of Two Rehabilitation Programs in Patients With Mild to Moderate Parkinson's Disease. Status COMPLETED Phase NA
NCT02796040 Exploration of Mesocorticolimbic Pathway in Impulse Control Disorders in Parkinson's Disease: Study Using Tensor Diffusion Imaging and Tractography. Status UNKNOWN Phase NA
NCT02786680 How Does STN-DBS Influence Emotional Conflict Decision in Parkinson's Disease: a EEG Study Status COMPLETED Phase NA
NCT02785510 Determining Clinical Profile of Parkinson's Disease Among Egyptian Population Status UNKNOWN Phase N/A
NCT02783014 Investigating Central Mechanisms of Overactive Bladder in Adults With Parkinson's Disease Status COMPLETED Phase N/A
NCT02782481 A Clinical Study Investigating the Efficacy, Tolerability, and Safety of Continuous Subcutaneous ND0612 Infusion Given as Adjunct Treatment to Oral Levodopa in Patients With Parkinson's Disease With Motor Fluctuations Status WITHDRAWN Phase PHASE3
NCT02777060 Exploring the Effectiveness of Sensor-based Balance Training on Patient Outcome Measures Status UNKNOWN Phase NA
NCT02774564 Pharmacokinetic-pharmacodynamic Interaction Between BIA 3-202 and Levodopa/Carbidopa Status COMPLETED Phase PHASE1
NCT02772627 Study to Investigate the Tolerability, Steady-state Pharmacokinetics and Erythrocyte COMT Inhibition of BIA 3-202 Status COMPLETED Phase PHASE1
NCT02772614 Absorption, Distribution, Metabolism and Excretion of [14C]-Labelled BIA 3-202 and Metabolites Status COMPLETED Phase PHASE1
NCT02768896 Monitoring Brain Waves in Response to Visual and/or Auditory Stimulation in Parkinson's Disease Patients Status UNKNOWN Phase NA
NCT02768077 Effect of Melatonin on Sleep Disturbances in Patients With Parkinson's Disease Status UNKNOWN Phase PHASE4
NCT02764892 A Study in Healthy Male Volunteers to Investigate a New Drug for the Treatment of Parkinson's Disease Status COMPLETED Phase PHASE1
NCT02764125 Efficacy and Safety Proof of Concept Study in Patients With Parkinson's Disease and End-of-dose Wearing-off (COMPOC) Status COMPLETED Phase PHASE2
NCT02763852 Pharmacokinetic-Pharmacodynamic Interaction Between Four Different Single Doses of BIA 3-202 and a Single Dose of Levodopa/Benserazide (100/25 mg) Status COMPLETED Phase PHASE1
NCT02763839 Pharmacokinetic-Pharmacodynamic Interaction Between Four Different Single Doses of BIA 3-202 and a Single Dose of Levodopa/Carbidopa (100/25 mg) Status COMPLETED Phase PHASE1